Anavex Life Sciences Corp.
| OTC Markets: AVXL
Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of novel drug targets to treat serious diseases. Its portfolio involves novel compounds directed to sigma receptor in preclinical and clinical stages of development that target neurodegenerative diseases and cancer. The company was founded by Harvey Lalach on January 23, 2004 and is headquartered in Vancouver, Canada.